• 1
    Fujii, S., Shimizu, K., Kronenberg, M. and Steinman, R. M., Prolonged interferon-γ producing NKT response induced with α-galactosylceramide-loaded dendritic cells. Nat. Immunol. 2002. 3: 867874.
  • 2
    Fujii, S., Shimizu, K., Hemmi, H., Fukui, M., Bonito, A. J., Chen, G., Franck, R. W. et al., Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA 2006. 103: 1125211257.
  • 3
    Fujii, S., Shimizu, K., Hemmi, H. and Steinman, R. M., Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol. Rev. 2007. 220: 183198.
  • 4
    Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y. and Bendelac, A., Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999. 163: 46474650.
  • 5
    Smyth, M. J., Wallace, M. E., Nutt, S. L., Yagita, H., Godfrey, D. I. and Hayakawa, Y., Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J. Exp. Med. 2005. 201: 19731985.
  • 6
    Granucci, F., Zanoni, I., Pavelka, N., Van Dommelen, S. L., Andoniou, C. E., Belardelli, F., Degli Esposti, M. A. and Ricciardi-Castagnoli, P., A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 2004. 200: 287295.
  • 7
    Andrews, D. M., Scalzo, A. A., Yokoyama, W. M., Smyth, M. J. and Degli-Esposti, M. A., Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 2003. 4: 175181.
  • 8
    Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M. C. and Moretta, A., Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006. 214: 219228.
  • 9
    Zanoni, I., Granucci, F., Foti, M. and Ricciardi-Castagnoli, P., Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells. Immunol. Lett. 2007. 110: 617.
  • 10
    Munz, C., Steinman, R. M. and Fujii, S., Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005. 202: 203207.
  • 11
    Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C., Scott, B., Schreiber, R. D., Hertzog, P. and Smyth, M. J., Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 2007. 178: 75407549.
  • 12
    van den Broeke, L. T., Daschbach, E., Thomas, E. K., Andringa, G. and Berzofsky, J. A., Dendritic cell-induced activation of adaptive and innate antitumor immunity. J. Immunol. 2003. 171: 58425852.
  • 13
    Prins, R. M., Vo, D. D., Khan-Farooqi, H., Yang, M. Y., Soto, H., Economou, J. S., Liau, L. M. and Ribas, A., NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. J. Immunol. 2006. 177: 84488455.
  • 14
    Adam, C., King, S., Allgeier, T., Braumuller, H., Luking, C., Mysliwietz, J., Kriegeskorte, A. et al., DC-NK cell cross talk as a novel CD4+T-cell-independent pathway for antitumor CTL induction. Blood 2005. 106: 338344.
  • 15
    Dworacki, G., Cicinnati, V. R., Beckebaum, S., Pizzoferrato, E., Hoffmann, T. K. and De Leo, A. B., Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice. Cancer Biol. Ther. 2005. 4: 5056.
  • 16
    Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S. et al., In vivo depletion of CD11c+ dendritic cells abrogation priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002. 17: 211220.
  • 17
    Kinjo, Y., Wu, D., Kim, G., Xing, G. W., Poles, M. A., Ho, D. D., Tsuji, M. et al., Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005. 434: 520525.
  • 18
    Kinjo, Y., Tupin, E., Wu, D., Fujio, M., Garcia-Navarro, R., Benhnia, M. R., Zajonc, D. M. et al., Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 2006. 7: 978986.
  • 19
    Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu C., III, Zhou, D., Saint-Mezard, P. et al., Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525529.
  • 20
    Nagarajan, N. A. and Kronenberg, M., Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 2007. 178: 27062713.
  • 21
    Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B., Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003. 4: 12301237.
  • 22
    Paget, C., Mallevaey, T., Speak, A. O., Torres, D., Fontaine, J., Sheehan, K. C., Capron, M. et al., Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007. 27: 597609.
  • 23
    Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004. 104: 32673275.
  • 24
    Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343351.
  • 25
    Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between Natural Killer cells and dendritic cells. J. Exp. Med. 2002. 195: 327333.
  • 26
    Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566571.
  • 27
    Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T. and Sakaguchi, S., Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 2007. 27: 145159.
  • 28
    Yamaguchi, T. and Sakaguchi, S., Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 2006. 16: 115123.
  • 29
    Berzofsky, J. A. and Terabe, M., NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J. Immunol. 2008. 180: 36273635.
  • 30
    Ambrosino, E., Terabe, M., Halder, R. C., Peng, J., Takaku, S., Miyake, S., Yamamura, T. et al., Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J. Immunol. 2007. 179: 51265136.
  • 31
    Akbari, O., Stock, P., Meyer, E. H., Freeman, G. J., Sharpe, A. H., Umetsu, D. T. and DeKruyff, R. H., ICOS/ICOSL interaction is required for CD4+invariant NKT cell function and homeostatic survival. J. Immunol. 2008. 180: 54485456.
  • 32
    Martin-Fontecha, A., Baumjohann, D., Guarda, G., Reboldi, A., Hons, M., Lanzavecchia, A. and Sallusto, F., CD40L+CD4+memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming. J. Exp. Med. 2008. 205: 25612574.
  • 33
    Shimizu, K., Goto, A., Fukui, M., Taniguchi, M. and Fujii, S., Tumor cells loaded with α-galactosylceramide Induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J. Immunol. 2007. 178: 28532861.
  • 34
    Shimizu, K., Kurosawa, Y., Taniguchi, M., Steinman, R. M. and Fujii, S., Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 2007. 204: 26412653.
  • 35
    Inaba, K., Swiggard, W. J., Steinman, R. M., Romani, N. and Schuler, G., Isolation of dendritic cells. Curr. protoc. Immunol. 1998. Chapter 3. unit
  • 36
    Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M. et al., Efficient presentation of phagocytosed cellular fragments on the MHC class II products of dendritic cells. J. Exp. Med. 1998. 188: 21632173.